CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Baclofendrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02298868
NCT02298868Phase 2Completed
CompareCT.gov

Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study

University of Virginia·interventional·Posted Nov 24, 2014·Updated Feb 5, 2015

In Brief

A Phase 2 clinical trial evaluating Baclofen for Muscle Cramps and Cirrhosis. Completed, enrolled 10 participants.

Detailed Summary

The purpose of this study is to determine the safety and efficacy of the medication Baclofen for treatment of muscle cramps in patients with cirrhosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Cramps, Cirrhosis
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 24, 2014
Enrollment StartOct 1, 2012
Primary CompletionNov 1, 2013
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 11.6 years ago

Interventions

Baclofendrug